Fisher Funds Management LTD purchased a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 166,158 shares of the medical equipment provider's stock, valued at approximately $86,676,000. Intuitive Surgical comprises about 2.1% of Fisher Funds Management LTD's holdings, making the stock its 15th biggest position.
Several other hedge funds and other institutional investors have also recently modified their holdings of ISRG. Howard Capital Management Group LLC raised its position in shares of Intuitive Surgical by 4.5% in the 3rd quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider's stock valued at $1,044,000 after purchasing an additional 92 shares during the last quarter. Foundations Investment Advisors LLC raised its position in shares of Intuitive Surgical by 8.5% in the 3rd quarter. Foundations Investment Advisors LLC now owns 590 shares of the medical equipment provider's stock valued at $290,000 after purchasing an additional 46 shares during the last quarter. Private Advisor Group LLC raised its position in shares of Intuitive Surgical by 6.4% in the 3rd quarter. Private Advisor Group LLC now owns 14,910 shares of the medical equipment provider's stock valued at $7,325,000 after purchasing an additional 891 shares during the last quarter. McAdam LLC purchased a new position in shares of Intuitive Surgical in the 3rd quarter valued at approximately $225,000. Finally, DT Investment Partners LLC raised its position in shares of Intuitive Surgical by 80.0% in the 3rd quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider's stock valued at $40,000 after purchasing an additional 36 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Several brokerages recently commented on ISRG. UBS Group increased their price objective on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a "neutral" rating in a research report on Monday, January 27th. Royal Bank of Canada raised their price target on shares of Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. Barclays raised their price target on shares of Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. Jefferies Financial Group lifted their price target on shares of Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Finally, Stifel Nicolaus lifted their price target on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a "buy" rating in a research note on Thursday, December 5th. One analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $613.10.
Check Out Our Latest Research Report on Intuitive Surgical
Insider Buying and Selling at Intuitive Surgical
In other news, EVP Robert Desantis sold 376 shares of Intuitive Surgical stock in a transaction on Friday, November 29th. The shares were sold at an average price of $539.00, for a total transaction of $202,664.00. Following the completion of the sale, the executive vice president now directly owns 5,506 shares of the company's stock, valued at approximately $2,967,734. The trade was a 6.39 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Jamie Samath sold 188 shares of Intuitive Surgical stock in a transaction on Friday, November 29th. The stock was sold at an average price of $539.00, for a total transaction of $101,332.00. Following the sale, the chief financial officer now directly owns 8,757 shares of the company's stock, valued at approximately $4,720,023. This trade represents a 2.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 6,240 shares of company stock valued at $3,529,040 in the last 90 days. Company insiders own 0.80% of the company's stock.
Intuitive Surgical Stock Down 2.9 %
ISRG stock traded down $17.27 during midday trading on Tuesday, hitting $573.74. The company's stock had a trading volume of 2,548,276 shares, compared to its average volume of 1,739,679. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00. The firm has a market capitalization of $204.35 billion, a P/E ratio of 89.51, a PEG ratio of 5.85 and a beta of 1.39. The firm has a 50-day simple moving average of $567.01 and a 200-day simple moving average of $527.27.
About Intuitive Surgical
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Stories

Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.